Dogwood Therapeutics, Inc. has regained compliance with Nasdaq's minimum bid price requirement after its stock closed at $1.00 or more for ten consecutive days, and the issue is now resolved.
AI Assistant
DOGWOOD THERAPEUTICS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.